DJIA 17,168.93 -3.75 -0.02%
NASDAQ 4,534.58 6.89 0.15%
S&P 500 1,992.35 -1.94 -0.10%
market minute promo

0.00 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

FRX $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS $3.78





Forest Laboratories, Inc. (FRX) Description

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Website:

News & Commentary Rss Feed

Why Salix Pharmaceuticals' Good Data Wasn't Great

Salix was short on specifics but word of a successful IBS-D study should calm some nervous stomachs among investors

Today In SA PRO: Wednesday, September 10

Today In SA PRO: Tuesday, September 9

Today In SA PRO: Monday, September 8

This Week's Outstanding Performance Winners - Jason Radin (Short Fairway) And Buddy Lyons (Long Fore

This Week's Outstanding Performance Winners - Jason Radin (Short Fairway) And Buddy Lyons (Long Forest Labs)

Why Endo International Can Deliver Solid Rewards With Minimal Risk

Bernard Horn Comments on Forest Laboratories

Bernard Horn's Polaris Global Value Fund 2Q 2014 Message to Our Shareholders

Global Guru Bernard Horn Reports his Top Five from the Second Quarter

Guru of the Year - Carl Icahn's Top Five Holdings

Carl Icahn Buys Gannett Co, eBay, Sells Forest Laboratories, Netflix, Family Dollar, Holds Herbalife

See More FRX News...

FRX's Top Competitors

FRX $0.00 (0.00%)
Current stock: FRX
JNJ $107.75 (-0.12%)
Current stock: JNJ
NVS $93.55 (-0.54%)
Current stock: NVS
RHHBY $37.53 (-0.36%)
Current stock: RHHBY